NASDAQ Issues Delisting Warning to Aimei Health for Delayed Quarterly Report
AFJK has more than doubled off its 52-week low of $6.75.
Summary
Aimei Health Technology Co., Ltd. (AFJK) has received a notice from NASDAQ regarding its non-compliance with listing rules due to the delayed filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2026. This follows the company's recently delayed annual report (10-K) which included a going concern warning, massive share redemptions, and material internal control weaknesses. The repeated reporting delays signal significant operational and financial distress, escalating concerns about the company's ability to meet its obligations and maintain its listing. AFJK now has 60 days to submit a plan to regain compliance, with potential delisting if it fails to do so. Traders will closely watch for the filing of the 10-Q and any further updates on its compliance status and proposed merger.
At the time of this announcement, AFJK was trading at $42.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $133.5M. The 52-week trading range was $6.75 to $130.37. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.